OGN (STOCKS)
Organon & Co.
$8.500000
-0.330000 (-3.74%)
Prev close: $8.830000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph T. Morrissey
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,225.70M
- Employees
- 10,000
- P/E (TTM)
- 12.31
- P/B (TTM)
- 3.06
- Dividend Yield
- 90.60%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
6
Hold
8
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.63 | $0.73 | -0.1044 | -14.22% |
|
Sep 2025 (Q3)
|
$1.01 | $0.95 | +0.0643 | +6.80% |
|
Jun 2025 (Q2)
|
$1.00 | $0.96 | +0.0427 | +4.46% |
|
Mar 2025 (Q1)
|
$1.02 | $0.91 | +0.1128 | +12.43% |
Financial Statements
| Revenues | $6.22B |
| Benefits Costs and Expenses | $5.79B |
| Cost Of Revenue | $2.90B |
| Costs And Expenses | $5.79B |
| Gross Profit | $3.31B |
| Operating Expenses | $2.89B |
| Selling, General, and Administrative Expenses | $1.72B |
| Other Operating Expenses | $1.17B |
| Operating Income/Loss | $425.00M |
| Income/Loss From Continuing Operations After Tax | $187.00M |
| Income/Loss From Continuing Operations Before Tax | $425.00M |
| Income Tax Expense/Benefit | $238.00M |
| Income Tax Expense/Benefit, Current | $175.00M |
| Income Tax Expense/Benefit, Deferred | $63.00M |
| Interest Expense, Operating | $504.00M |
| Net Income/Loss | $187.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $187.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $187.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.72 |
| Diluted Earnings Per Share | $0.72 |
| Basic Average Shares | 259,495,000 |
| Diluted Average Shares | 260,764,000 |
| Assets | $12.87B |
| Current Assets | $4.35B |
| Inventory | $1.41B |
| Other Current Assets | $2.95B |
| Noncurrent Assets | $8.52B |
| Fixed Assets | $1.30B |
| Intangible Assets | $1.13B |
| Other Non-current Assets | $6.08B |
| Liabilities | $12.12B |
| Current Liabilities | $2.39B |
| Accounts Payable | $952.00M |
| Other Current Liabilities | $1.44B |
| Noncurrent Liabilities | $9.73B |
| Long-term Debt | $8.64B |
| Other Non-current Liabilities | $1.08B |
| Equity | $752.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $752.00M |
| Liabilities And Equity | $12.87B |
| Net Cash Flow From Operating Activities | $700.00M |
| Net Cash Flow From Operating Activities, Continuing | $700.00M |
| Net Cash Flow From Investing Activities | -$390.00M |
| Net Cash Flow From Investing Activities, Continuing | -$390.00M |
| Net Cash Flow From Financing Activities | -$561.00M |
| Net Cash Flow From Financing Activities, Continuing | -$561.00M |
| Exchange Gains/Losses | $150.00M |
| Net Cash Flow | -$101.00M |
| Net Cash Flow, Continuing | -$251.00M |
| Comprehensive Income/Loss | $309.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $309.00M |
| Other Comprehensive Income/Loss | $122.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $122.00M |